Document Detail

The medical management of pediatric arrhythmias.
MedLine Citation:
PMID:  22907424     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Arrhythmias are an important cause of morbidity and mortality in children. Despite recent technological advances in treatment, pharmacologic therapy remains the most common treatment modality for pediatric arrhythmias. The choice of antiarrhythmic agent, the duration of therapy, and the dosing schedule depend on multiple factors including the recurrence risk and the arrhythmia burden (the latter being determined by the hemodynamic effect of the arrhythmia), and the frequency and duration of episodes. As with all pediatric medications, consideration must be given to the drug formulation, palatability, adverse effects and adherence issues. There are very few randomized trials available to guide the choice of therapy for pediatric arrhythmias, and thus treatment options often reflect physician or institutional preferences. Although various classification schemes exist, we classify antiarrhythmic agents based on their primary site of action: atrial muscle/accessory pathway (class IA, IC, and III agents); the atrioventricular node (beta-blockers, calcium channel blockers, digoxin, and class III agents); or ventricular muscle (class I and III agents). This type of categorization assists in the approach to treatment required for each type of arrhythmia encountered.
Carolina Escudero; Roxane Carr; Shubhayan Sanatani
Related Documents :
2071254 - Arrhythmias, haemodynamic changes and extent of myocardial damage during coronary ligat...
7449054 - Effects of coronary artery reperfusion on myocardial infarct size and survival in consc...
21720264 - In-treatment stroke volume predicts cardiovascular risk in hypertension.
22254214 - Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new.
10840494 - Transient ischaemic attacks and stroke.
16003454 - Transesophageal echocardiographic diagnosis of ventricular noncompaction associated wit...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current treatment options in cardiovascular medicine     Volume:  14     ISSN:  1534-3189     ISO Abbreviation:  Curr Treat Options Cardiovasc Med     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-05     Completed Date:  2012-10-02     Revised Date:  2013-07-25    
Medline Journal Info:
Nlm Unique ID:  9815942     Medline TA:  Curr Treat Options Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  455-72     Citation Subset:  -    
Division of Cardiology, British Columbia Children's Hospital, 4480 Oak Street, 1F Clinic, Vancouver, BC, V6H 3V4, Canada,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulin...
Next Document:  Clinical and histologic effects from CO(2) laser treatment of keloids.